Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
01/2014
01/01/2014CN103483316A 5-acetic acid-1-(6-bromopyridine)-1 hydrogen-pyrazole-3-methyl acetate and synthesis method thereof
01/01/2014CN103483315A 7-(3-aminomethyl-4-alkoxyimino-1-piperidyl)-1-[(1R,2S)-2-fluorocyclopropyl] quinolone carboxylic acid compounds and preparation method thereof
01/01/2014CN103483314A Method for preparing imatinib mesylate in alpha crystal form conveniently and rapidly
01/01/2014CN103483313A Novel hydrazide derivatives as well as preparation method and application thereof
01/01/2014CN103483267A Diverse arylimidazole quaternary ammonium salt, preparation method and application thereof
01/01/2014CN103483260A 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
01/01/2014CN103483251A 病毒聚合酶抑制剂 Viral polymerase inhibitor
01/01/2014CN103483235A Insecticidal aryl pyrrolidines
01/01/2014CN103483234A Cyclopropyl amine derivatives
01/01/2014CN102675288B 2-((2-(bi(2-picolyl) amino) ethyl) amino)-4-(3,6,6-trimethyl-4-oxyl-4,5,6,7-tetrahydroindazolyl) benzamide and preparation as well as application
01/01/2014CN102464611B Substitutional biaryl base benzene sulfonamide compound and application
01/01/2014CN102292318B Method for preparing activated esters
01/01/2014CN101679244B 5-membered heterocyclic derivative and use thereof for medical purposes
01/01/2014CN101528728B 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
12/2013
12/31/2013US8618304 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
12/31/2013US8618303 Pyrrolidine derivatives
12/31/2013US8618302 Methods and compositions of targeted drug development
12/31/2013US8618296 Arylethynyl derivatives
12/31/2013US8618290 HSP90 inhibitors
12/31/2013US8618287 Derivatives of triazines and uracils, their preparation and their application in human therapeutics
12/31/2013US8618285 Triazole derivatives
12/31/2013US8618159 Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/31/2013US8618140 P38 MAP kinase inhibitors
12/31/2013US8618137 Fungicidal heterocyclic compounds
12/31/2013US8618132 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
12/31/2013US8618131 Biphenyl derivatives
12/31/2013US8618112 Crystalline forms of an inhibitor of 11-β-hydroxysteroid dehydrogenase type 1
12/31/2013US8618111 5-alkynyl-pyrimidines
12/31/2013US8618110 Compositions and methods for apoptosis modulators
12/31/2013US8618094 Fused substituted aminopyrrolidine derivative
12/31/2013CA2778894C Compounds for measuring nitroreductase enzyme activity
12/31/2013CA2742833C Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
12/31/2013CA2629814C Bisamide inhibitors of hedgehog signaling
12/31/2013CA2613192C Histamine h3 receptor agents, preparation and therapeutic uses
12/31/2013CA2599974C Pyridine-2-carboxamide derivatives as mglur5 antagonists
12/31/2013CA2587489C Mediators of hedgehog signaling pathways, compositions and uses related thereto
12/31/2013CA2552565C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
12/31/2013CA2544678C Modulators of cellular adhesion
12/27/2013WO2013192345A1 Complement pathway modulators and uses thereof
12/27/2013WO2013192286A1 Iap antagonists
12/27/2013WO2013192049A2 1,2,4-triazine-6-carboxamide kinase inhibitors
12/27/2013WO2013192046A2 Substituted picolinamide kinase inhibitors
12/27/2013WO2013191401A1 Composition for treating or preventing diseases caused by vascular permeability, containing imatinib or pharmaceutically acceptable salt thereof as active ingredient
12/27/2013WO2013191177A1 Cyclic azine compound, method for producing same, and organic electroluminescent element containing same
12/27/2013WO2013191113A1 Fused heterocyclic compound
12/27/2013WO2013190329A1 Analytical method on the basis of electron spin resonance (esr) and probe|molecule
12/27/2013WO2013190302A1 Camsylate salt
12/27/2013WO2013190300A1 Cyclohexane-1,2'-naphthalene-1',2"-imidazole compounds and their use as bace inhibitors
12/27/2013WO2013190298A1 2h-imidazol-4-amine compounds and their use as bace inhibitors
12/27/2013WO2013189910A1 Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers
12/27/2013WO2013168688A8 Organic electroluminescence element, illumination device, and display device
12/27/2013WO2012162635A8 Metabotropic glutamate receptors 5 modulators and methods of use thereof
12/27/2013CA2877526A1 Complement pathway modulators and uses thereof
12/27/2013CA2877469A1 Substituted picolinamide kinase inhibitors
12/27/2013CA2877030A1 Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers
12/27/2013CA2876945A1 1,2,4-triazine-6-carboxamide kinase inhibitors
12/27/2013CA2876926A1 Composition for treating or preventing vascular permeability-related disease containing imatinib or pharmaceutically acceptable salt thereof as active ingredient
12/27/2013CA2875944A1 Novel anti-cancer compounds
12/27/2013CA2875589A1 Camsylate salt
12/27/2013CA2875497A1 Cyclohexane-1,2'-naphthalene-1',2"-imidazole compounds and their use as bace inhibitors
12/27/2013CA2875494A1 2h-imidazol-4-amine compounds and their use as bace inhibitors
12/27/2013CA2875389A1 1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives
12/26/2013US20130345427 Colorant compound derived from genipa americana genipin and glycine
12/26/2013US20130345261 Benzimidazole inhibition of biofilm formation
12/26/2013US20130345258 Amino-quinolines as kinase inhibitors
12/26/2013US20130345251 Large substituent, non-phenolic opioids and methods of use thereof
12/26/2013US20130345248 Cyclohexane-1,2'-Naphthalene-1',2"-Imidazol Compounds and Their Use as Bace
12/26/2013US20130345247 Cyclohexane-1,2'-Indene-1',2"-Imidazol Compounds and Their Use as Bace Inhibitors
12/26/2013US20130345246 2H-Imidazol-4-Amine Compounds and Their Use as Bace Inhibitors
12/26/2013US20130345240 Compounds that modulate intracellular calcium
12/26/2013US20130345233 Inhibitors of protein kinases
12/26/2013US20130345223 Compounds and methods for treating tuberculosis infection
12/26/2013US20130345212 Quinolinone derivatives
12/26/2013US20130345211 Pyridine Compounds as Sodium Channel Blockers
12/26/2013US20130345208 Ion channel modulators and methods of use
12/26/2013US20130345200 Indoles
12/26/2013US20130345199 1-[m-carboxamido(hetero)aryl-methyl]-piperidine-4-carboxamide derivatives
12/26/2013US20130345192 Heterocyclic tyrosine kinase inhibitors
12/26/2013US20130345191 1,2,4-triazine-6-carboxamide kinase inhibitors
12/26/2013US20130345180 2,4- diaminopyrimidine derivatives
12/26/2013US20130345120 Peptide deformylase inhibitors
12/26/2013US20130344061 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors
12/26/2013US20130343993 Radiolabeled 5-ht6 ligands
12/26/2013US20130343992 Radiolabeled pde10a ligands
12/25/2013EP2677560A1 Organic electroluminescence element and illumination device
12/25/2013EP2676956A1 Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
12/25/2013EP2675794A1 Selective fak inhibitors
12/25/2013EP2675793A1 Fak inhibitors
12/25/2013EP2675791A1 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
12/25/2013EP2675787A1 Aminoindane compounds and use thereof in treating pain
12/25/2013EP2468729B1 Novel indazole derivative
12/25/2013EP2429295B1 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
12/25/2013EP2424855B1 New photoinitiators
12/25/2013EP2406248B1 Novel isoindolin-1-one derivative
12/25/2013EP2393777B1 Hydrazide compound and use of the same in pest control
12/25/2013EP2350311B1 Diacylglycerol acyltransferase inhibitors
12/25/2013EP2344459B1 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as fxr modulators against dyslipidemia and related diseases
12/25/2013EP2163553B1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
12/25/2013EP2152670B1 Bridged six-membered ring compounds
12/25/2013EP2142529B1 Trpv1 antagonists and uses thereof
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 1080